Metropolitan Life Insurance CO Lyell Immunopharma, Inc. Transaction History

Metropolitan Life Insurance CO

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.71 - $3.07 $482 - $865	282 Added 4.45%	6,619 $14,000
Q4 2023 Feb 14, 2024	SELL	$1.39 - $2.35 $4,881 - $8,253	-3,512 Reduced 35.66%	6,337 $12,000
Q1 2023 May 15, 2023	SELL	$1.97 - $3.58 $1,747 - $3,175	-887 Reduced 8.26%	9,849 $23,000
Q4 2022 Jun 14, 2023	BUY	$2.78 - $8.09 $2,465 - $7,175	887 Added 9.01%	10,736 $37.3 Million
Q3 2022 Jun 14, 2023	BUY	$5.54 - $8.27 $4,913 - $7,335	887 Added 9.01%	10,736 $78.7 Million
Q2 2022 Jun 20, 2023	BUY	$3.68 - $6.8 $3,264 - $6,031	887 Added 9.01%	10,736 $69,000
Q2 2022 Mar 30, 2023	BUY	$3.68 - $6.8 $3,069 - $5,671	834 Added 8.42%	10,736 $69,000
Q2 2022 Aug 11, 2022	BUY	$3.68 - $6.8 $3,069 - $5,671	834 Added 8.42%	10,736 $70,000
Q1 2022 Jun 20, 2023	BUY	$5.05 - $7.7 $267 - $408	53 Added 0.54%	9,902 $50,000
Q1 2022 Mar 30, 2023	BUY	$5.05 - $7.7 $10,569 - $16,116	2,093 Added 26.8%	9,902 $50,000
Q1 2022 May 12, 2022	BUY	$5.05 - $7.7 $50,005 - $76,245	9,902 New	9,902 $50,000
Q4 2021 Feb 15, 2022	SELL	$7.13 - $15.19 $55,678 - $118,618	-7,809 Closed	0 $0
Q3 2021 Jun 21, 2023	SELL	$11.0 - $17.95 $22,440 - $36,618	-2,040 Reduced 20.71%	7,809 $115,000
Q3 2021 Mar 30, 2023	SELL	$11.0 - $17.95 $32,197 - $52,539	-2,927 Reduced 27.26%	7,809 $115,000
Q3 2021 Nov 15, 2021	BUY	$11.0 - $17.95 $85,899 - $140,171	7,809 New	7,809 $116,000

121

142M

18.1K

200

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $151M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.